Back to BA Baupost Group LLC

JAZZJAZZ

Showing 1 of 7 quarters

Position history for BABaupost Group LLC's holdings in Jazz Pharmaceuticals plc

No. Baupost Group exited its JAZZ (Jazz Pharmaceuticals) position in Q3 2024. Its Q2 2024 13F listed 1,274,248 shares worth $136M. Baupost Group first reported JAZZ in Q1 2023 and held it in 6 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

$0

Total Shares Change

0

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q3
Latest
Exited
0
-100.0%
$00.0%$111.41
0

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used